Segui
Marcelo Eduardo Bigal
Marcelo Eduardo Bigal
Head of the Merck Investigator Sudies Program, Scientific Engagements and Education
Email verificata su merck.com
Titolo
Citata da
Citata da
Anno
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
27465*2014
The international classification of headache disorders, (beta version)
Headache Classification Committee of the International Headache Society (IHS)
Cephalalgia 33 (9), 629-808, 2013
60862013
Migraine prevalence, disease burden, and the need for preventive therapy
RB Lipton, ME Bigal, M Diamond, F Freitag, ML Reed, WF Stewart
Neurology 68 (5), 343-349, 2007
24382007
Migraine and cardiovascular disease: systematic review and meta-analysis
M Schrks, PM Rist, ME Bigal, JE Buring, RB Lipton, T Kurth
Bmj 339, 2009
8832009
Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population‐based study
ME Bigal, D Serrano, D Buse, A Scher, WF Stewart, RB Lipton
Headache: The Journal of Head and Face Pain 48 (8), 1157-1168, 2008
8392008
Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment
ME Bigal, D Serrano, M Reed, RB Lipton
Neurology 71 (8), 559-566, 2008
734*2008
Fremanezumab for the preventive treatment of chronic migraine
SD Silberstein, DW Dodick, ME Bigal, PP Yeung, PJ Goadsby, ...
New England Journal of Medicine 377 (22), 2113-2122, 2017
5542017
Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double‐blind, placebo‐controlled trial
SD Silberstein, RB Lipton, DW Dodick, FG Freitag, N Ramadan, ...
Headache: The Journal of Head and Face Pain 47 (2), 170-180, 2007
5262007
Migraine: epidemiology, impact, and risk factors for progression
RB Lipton, ME Bigal
Headache: The Journal of Head and Face Pain 45, S3-S13, 2005
5192005
Cutaneous allodynia in the migraine population
RB Lipton, ME Bigal, S Ashina, R Burstein, S Silberstein, ML Reed, ...
Annals of neurology 63 (2), 148-158, 2008
5062008
Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study: CME
S Diamond, ME Bigal, S Silberstein, E Loder, M Reed, RB Lipton
Headache: The Journal of Head and Face Pain 47 (3), 355-363, 2007
5052007
Obesity and migraine: a population study
ME Bigal, JN Liberman, RB Lipton
Neurology 66 (4), 545-550, 2006
4562006
Modifiable risk factors for migraine progression
ME Bigal, RB Lipton
Headache: The Journal of Head and Face Pain 46 (9), 1334-1343, 2006
4122006
Migraine and cardiovascular disease: a population-based study
ME Bigal, T Kurth, N Santanello, D Buse, W Golden, M Robbins, ...
Neurology 74 (8), 628-635, 2010
4062010
Obesity is a risk factor for transformed migraine but not chronic tension-type headache
ME Bigal, RB Lipton
Neurology 67 (2), 252-257, 2006
3902006
Effect of fremanezumab compared with placebo for prevention of episodic migraine: a randomized clinical trial
DW Dodick, SD Silberstein, ME Bigal, PP Yeung, PJ Goadsby, ...
Jama 319 (19), 1999-2008, 2018
3852018
The epidemiology, burden, and comorbidities of migraine
ME Bigal, RB Lipton
Neurologic clinics 27 (2), 321-334, 2009
3752009
Chronic disorders with episodic manifestations: focus on epilepsy and migraine
SR Haut, ME Bigal, RB Lipton
The Lancet Neurology 5 (2), 148-157, 2006
3692006
Prevalence and characteristics of allodynia in headache sufferers: a population study
ME Bigal, S Ashina, R Burstein, ML Reed, D Buse, D Serrano, RB Lipton
Neurology 70 (17), 1525-1533, 2008
3682008
Symptoms of temporomandibular disorders in the population: an epidemiological study.
DA de Godoi Gonalves, AL Dal Fabbro, JADB Campos, ME Bigal, ...
Journal of orofacial pain 24 (3), 2010
3612010
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20